SMAC exhibits anti-tumor effects in ECA109 cells by regulating expression of inhibitor of apoptosis protein family

BACKGROUND: The poor prognosis and rising incidence of esophageal cancer highlight the need for improved therapeutics that are essential prior to treatment. LCL161 is an SMAC (second mitochondrial activator of caspases) mimic and inhibitor of apoptosis protein (IAP) antagonist which exhibits anti-tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Ning, Zhang, Wei-Quan, Dong, Hong, Hao, Ying-Tao, Zhang, Li-Ming, Shan, Lei, Yang, Xiao-Dong, Peng, Chuan-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283620/
https://www.ncbi.nlm.nih.gov/pubmed/34307552
http://dx.doi.org/10.12998/wjcc.v9.i19.5019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283620/
https://www.ncbi.nlm.nih.gov/pubmed/34307552
http://dx.doi.org/10.12998/wjcc.v9.i19.5019

Ejemplares similares